Cohero Health has announced 5 new hires “to scale for growth and drive commercial sales of its BreatheSmart platform.” In 2016, Cohero and H&T Presspart announced that they had partnered on development of an electronic inhaler called the eMDI.
The new hires are: Amber Thompson, Chief Client Officer; Sergio Carbone, Chief Information and Technology Officer; Yury Rozenman, Senior VP Life Sciences & MedTech; Dan Glazerman, VP, Manufacturing, Operations & Hardware Development; and Allen Ehrlich, VP of Marketing.
Cohero Health CEO Joe Condurso commented, “We are honored to add such a talented group of senior executives to Cohero Health which acknowledges the bold vision and transformative nature and mission of our company as we expand our commercialization and reach of the BreatheSmart connected platform to pharmaceutical and medical technology companies, providers, payers, and consumers. This expansion is an integral part of the company’s go-to-market strategy. Cohero Health is uniquely positioned to address the economic burden in the US of $133 billion for asthma and COPD with a best-in-class digital platform and suite of proprietary connected devices for patient medication adherence and mobile lung function measurement.”
Read the Cohero Health press release.
